A Study to Investigate the Analgesic Efficacy of AZD2423 Compared With Placebo After 28 Days Treatment in Patients With Painful Diabetic Polyneuropathy

PHASE2CompletedINTERVENTIONAL
Enrollment

134

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions
Neuropathic Pain
Interventions
DRUG

AZD2423

20 mg tablet

DRUG

AZD2423

150 mg tablet

DRUG

Placebo

Placebo

Trial Locations (20)

Unknown

Research Site, Goodyear

Research Site, Phoenix

Research Site, Tucson

Research Site, Los Angeles

Research Site, DeLand

Research Site, Miami

Research Site, Orlando

Research Site, Sunrise

Research Site, Madisonville

Research Site, Willingboro

Research Site, New York

Research Site, Winston-Salem

Research Site, Philadelphia

Research Site, Houston

Research Site, Winnipeg

Research Site, Brampton

Research Site, Etobicoke

Research Site, Mississauga

Research Site, Lachine

Research Site, Laval

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY